Boing Boing

Boing Boing

23andme's prospects for survival dim

The data's going to be sold, isn't it?

Rob Beschizza
Oct 04, 2024
∙ Paid
Share

23andme
Image: 23andme

Genetic surveillance company 23andMe, once a $6bn prospect, is now a penny stock on the verge of doom. So "what happens to all its DNA data?" asks NPR.

As 23andMe struggles for survival, customers like Wiles have one pressing question: What is the company's plan for all the data it has collected since it was founded in 2006?

"I absolutely th…

Keep reading with a 7-day free trial

Subscribe to Boing Boing to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Happy Mutants LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture